HLS Therapeutics Inc. (HLTRF)

USD 2.96

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 207.99 Million 241.65 Million 275.9 Million 303.9 Million 319.67 Million 306.42 Million
Total Current Assets 43.86 Million 44.37 Million 43.75 Million 45.91 Million 63.1 Million 31.61 Million
Cash And Short Term Investments 21.83 Million 20.72 Million 21.17 Million 20.61 Million 47.07 Million 10.93 Million
Cash and Cash Equivalents 21.83 Million 20.72 Million 21.17 Million 20.61 Million 47.07 Million 10.93 Million
Short Term Investments - - - - - -
Net Receivables 10.63 Million 11.19 Million 11.51 Million 12.49 Million 11.85 Million 17.5 Million
Inventory 9.48 Million 8.9 Million 8.92 Million 10.63 Million 2.05 Million 1.5 Million
Other Current Assets 1.9 Million 3.55 Million 2.13 Million 2.17 Million 2.1 Million 1.67 Million
Total Non-Current Assets 164.12 Million 197.27 Million 232.15 Million 257.99 Million 256.57 Million 274.8 Million
Net PPE 960.06 Thousand 1.12 Million 1.56 Million 1.38 Million 1.27 Million 363 Thousand
Good Will And Intangible Assets 162.34 Million 195.01 Million 229.18 Million 253.4 Million 252.05 Million 271.15 Million
Good Will - - - - - -
Intangible Assets 162.34 Million 195.01 Million 229.18 Million 253.4 Million 252.05 Million 271.15 Million
Long-Term Investments -830.6 Thousand 667.69 Thousand 713.03 Thousand 2.03 Million 2.18 Million 2.29 Million
Tax Assets 1.03 Million 465 Thousand 690 Thousand 1.17 Million 1.05 Million 1 Million
Other Non Current Assets 615.83 Thousand 303.00 967.00 - - -
Other Assets 1.00 - - - - -
Total Liabilities 110.79 Million 116.33 Million 115.16 Million 134.65 Million 141.47 Million 147.93 Million
Total Current Liabilities 26.55 Million 31.19 Million 27.67 Million 35.64 Million 47.13 Million 38.26 Million
Account Payables 14.03 Million 11.59 Million 9.31 Million 14.22 Million 13.46 Million 12.4 Million
Tax Payables 279.56 Thousand - 97 Thousand 545 Thousand 347 Thousand 369 Thousand
Short Term Debt 5.12 Million 13.58 Million 12.6 Million 10.14 Million 6.04 Million 5 Million
Deferred Revenue 279.56 Thousand 4.12 Million 4.84 Million 5.06 Million 5.81 Million 6.94 Million
Other Current Liabilities 7.1 Million 1.88 Million 901 Thousand 6.21 Million 21.81 Million 13.92 Million
Total Non Current Liabilities 84.24 Million 85.14 Million 87.49 Million 99.01 Million 94.33 Million 109.66 Million
Long-Term Debt 81.62 Million 83.76 Million 84.96 Million 96.98 Million 87.06 Million 91.7 Million
Deferred Revenue Non Current 417.85 Thousand - - - 2.19 Million 2.29 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.75 Million 817 Thousand 1.88 Million 2.03 Million 2.55 Million 10.46 Million
Other Liabilities - - - - - -
Total Equity 97.19 Million 125.31 Million 160.73 Million 169.24 Million 178.19 Million 158.48 Million
Stock Holders Equity 97.19 Million 125.31 Million 160.73 Million 169.24 Million 178.19 Million 158.48 Million
Common Stock 260.78 Million 265.2 Million 265.91 Million 257.41 Million 248.68 Million 210.36 Million
Retained Earnings -174.55 Million -148.44 Million -119.85 Million -101.57 Million -81.46 Million -57.38 Million
Accumulated other comprehensive income -2.82 Million -5.26 Million 2.95 Million 2.02 Million -537 Thousand -7.45 Million
Common Stock Equity 97.19 Million 125.31 Million 160.73 Million 169.24 Million 178.19 Million 158.48 Million
Capital Lease Obligation 417.85 Thousand 1.01 Million 1.43 Million 1.16 Million 903 Thousand -
Total Investments -830.6 Thousand 667.69 Thousand 713.03 Thousand 2.03 Million 2.18 Million 2.29 Million
Total Debt 87.17 Million 97.34 Million 97.56 Million 107.12 Million 93.11 Million 96.7 Million
Net Debt 65.33 Million 76.62 Million 76.38 Million 86.51 Million 46.03 Million 85.77 Million

Balance Sheet Charts

Created with Highcharts 11.1.0Value in USDYearly Balance Sheet BreakdownCurrent AssetsNon-Current AssetsCurrent LiabilitiesNon-Current LiabilitiesEquity20202021202220230100 M200 M300 M400 M
Created with Highcharts 11.1.0Current RatioWorking CapitalAnnual Working CapitalSource: YRWorking CapitalCurrrent Ratio20202021202220231.21.31.41.51.61.704 M8 M12 M16 M20 M